BioCentury
ARTICLE | Company News

Amersham Pharmacia licenses VITX's Inactine

May 3, 2000 7:00 AM UTC

Amersham Pharmacia Biotech received exclusive worldwide distribution rights for V.I. Technologies' Inactine small molecule electrophilic nucleic acid binders virus inactivation technology. Separately,...